Search For "investigational antiviral candidate"
Pfizer says its COVID-19 oral antiviral candidate reduces risk of hospital
Updated : 4 years, 9 months ago IST
New York [US], November 5 (ANI): American pharmaceutical company Pfizer announced on Friday that its investigational COVID-19 oral antiviral candidate, Paxlovid, showed an 89 per cent reduction in hospitalisation or lethal cases in high-risk patients.
Read More